nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranitidine—CYP1A2—chronic obstructive pulmonary disease	0.427	1	CbGaD
Ranitidine—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0497	0.12	CbGbCtD
Ranitidine—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0497	0.12	CbGbCtD
Ranitidine—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.039	0.0938	CbGbCtD
Ranitidine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0378	0.0909	CbGbCtD
Ranitidine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0378	0.0909	CbGbCtD
Ranitidine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0337	0.081	CbGbCtD
Ranitidine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0317	0.0763	CbGbCtD
Ranitidine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0214	0.0515	CbGbCtD
Ranitidine—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0209	0.0502	CbGbCtD
Ranitidine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0204	0.0491	CbGbCtD
Ranitidine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0182	0.0438	CbGbCtD
Ranitidine—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0178	0.0429	CbGbCtD
Ranitidine—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0168	0.0405	CbGbCtD
Ranitidine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0107	0.0257	CbGbCtD
Ranitidine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0101	0.0243	CbGbCtD
Ranitidine—Angina pectoris—Arformoterol—chronic obstructive pulmonary disease	0.000596	0.00491	CcSEcCtD
Ranitidine—Angina pectoris—Formoterol—chronic obstructive pulmonary disease	0.000596	0.00491	CcSEcCtD
Ranitidine—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.000594	0.00489	CcSEcCtD
Ranitidine—Pancreatitis—Montelukast—chronic obstructive pulmonary disease	0.000588	0.00484	CcSEcCtD
Ranitidine—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.000586	0.00483	CcSEcCtD
Ranitidine—Arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.000575	0.00473	CcSEcCtD
Ranitidine—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.000569	0.00468	CcSEcCtD
Ranitidine—Bronchospasm—Salbutamol—chronic obstructive pulmonary disease	0.000568	0.00468	CcSEcCtD
Ranitidine—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000565	0.00465	CcSEcCtD
Ranitidine—Angina pectoris—Salbutamol—chronic obstructive pulmonary disease	0.000563	0.00464	CcSEcCtD
Ranitidine—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000545	0.00449	CcSEcCtD
Ranitidine—Delusion—Prednisone—chronic obstructive pulmonary disease	0.000542	0.00447	CcSEcCtD
Ranitidine—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.000542	0.00447	CcSEcCtD
Ranitidine—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000542	0.00446	CcSEcCtD
Ranitidine—Vasculitis—Prednisolone—chronic obstructive pulmonary disease	0.000541	0.00446	CcSEcCtD
Ranitidine—Pneumonia—Montelukast—chronic obstructive pulmonary disease	0.000538	0.00443	CcSEcCtD
Ranitidine—Mania—Prednisone—chronic obstructive pulmonary disease	0.000528	0.00435	CcSEcCtD
Ranitidine—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.000521	0.00429	CcSEcCtD
Ranitidine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.000515	0.00424	CcSEcCtD
Ranitidine—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000505	0.00416	CcSEcCtD
Ranitidine—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.000502	0.00414	CcSEcCtD
Ranitidine—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.000498	0.0041	CcSEcCtD
Ranitidine—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.000494	0.00407	CcSEcCtD
Ranitidine—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.000483	0.00398	CcSEcCtD
Ranitidine—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.00048	0.00395	CcSEcCtD
Ranitidine—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.000477	0.00393	CcSEcCtD
Ranitidine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000469	0.00386	CcSEcCtD
Ranitidine—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000457	0.00377	CcSEcCtD
Ranitidine—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.000454	0.00374	CcSEcCtD
Ranitidine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000453	0.00373	CcSEcCtD
Ranitidine—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00045	0.0037	CcSEcCtD
Ranitidine—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.00045	0.0037	CcSEcCtD
Ranitidine—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.00045	0.0037	CcSEcCtD
Ranitidine—Delirium—Prednisone—chronic obstructive pulmonary disease	0.000446	0.00368	CcSEcCtD
Ranitidine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000446	0.00368	CcSEcCtD
Ranitidine—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.000438	0.0036	CcSEcCtD
Ranitidine—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.000438	0.0036	CcSEcCtD
Ranitidine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000436	0.00359	CcSEcCtD
Ranitidine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000432	0.00356	CcSEcCtD
Ranitidine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000432	0.00356	CcSEcCtD
Ranitidine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00043	0.00354	CcSEcCtD
Ranitidine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000427	0.00352	CcSEcCtD
Ranitidine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000421	0.00347	CcSEcCtD
Ranitidine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000414	0.00341	CcSEcCtD
Ranitidine—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000413	0.0034	CcSEcCtD
Ranitidine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000407	0.00335	CcSEcCtD
Ranitidine—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000396	0.00326	CcSEcCtD
Ranitidine—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000396	0.00326	CcSEcCtD
Ranitidine—Vasculitis—Prednisone—chronic obstructive pulmonary disease	0.000393	0.00324	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000393	0.00324	CcSEcCtD
Ranitidine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000392	0.00323	CcSEcCtD
Ranitidine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000392	0.00323	CcSEcCtD
Ranitidine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00039	0.00321	CcSEcCtD
Ranitidine—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.00039	0.00321	CcSEcCtD
Ranitidine—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.00039	0.00321	CcSEcCtD
Ranitidine—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000385	0.00317	CcSEcCtD
Ranitidine—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000385	0.00317	CcSEcCtD
Ranitidine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000384	0.00316	CcSEcCtD
Ranitidine—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000382	0.00314	CcSEcCtD
Ranitidine—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000374	0.00308	CcSEcCtD
Ranitidine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00037	0.00305	CcSEcCtD
Ranitidine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000369	0.00304	CcSEcCtD
Ranitidine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000368	0.00303	CcSEcCtD
Ranitidine—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000365	0.003	CcSEcCtD
Ranitidine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000363	0.00299	CcSEcCtD
Ranitidine—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000363	0.00299	CcSEcCtD
Ranitidine—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000363	0.00299	CcSEcCtD
Ranitidine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000363	0.00299	CcSEcCtD
Ranitidine—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000363	0.00299	CcSEcCtD
Ranitidine—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000363	0.00299	CcSEcCtD
Ranitidine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000363	0.00299	CcSEcCtD
Ranitidine—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000363	0.00299	CcSEcCtD
Ranitidine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000362	0.00298	CcSEcCtD
Ranitidine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000361	0.00298	CcSEcCtD
Ranitidine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000361	0.00298	CcSEcCtD
Ranitidine—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000359	0.00295	CcSEcCtD
Ranitidine—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000359	0.00295	CcSEcCtD
Ranitidine—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000356	0.00293	CcSEcCtD
Ranitidine—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000356	0.00293	CcSEcCtD
Ranitidine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000348	0.00287	CcSEcCtD
Ranitidine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000348	0.00287	CcSEcCtD
Ranitidine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000343	0.00282	CcSEcCtD
Ranitidine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000343	0.00282	CcSEcCtD
Ranitidine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000343	0.00282	CcSEcCtD
Ranitidine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000343	0.00282	CcSEcCtD
Ranitidine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000341	0.00281	CcSEcCtD
Ranitidine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000341	0.00281	CcSEcCtD
Ranitidine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00034	0.0028	CcSEcCtD
Ranitidine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00034	0.0028	CcSEcCtD
Ranitidine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000339	0.00279	CcSEcCtD
Ranitidine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000337	0.00277	CcSEcCtD
Ranitidine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000334	0.00275	CcSEcCtD
Ranitidine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000329	0.00271	CcSEcCtD
Ranitidine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000325	0.00268	CcSEcCtD
Ranitidine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000325	0.00268	CcSEcCtD
Ranitidine—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000325	0.00268	CcSEcCtD
Ranitidine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000324	0.00266	CcSEcCtD
Ranitidine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000321	0.00264	CcSEcCtD
Ranitidine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000318	0.00262	CcSEcCtD
Ranitidine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000318	0.00262	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000317	0.00261	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000317	0.00261	CcSEcCtD
Ranitidine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000315	0.00259	CcSEcCtD
Ranitidine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000315	0.00259	CcSEcCtD
Ranitidine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000313	0.00258	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000311	0.00256	CcSEcCtD
Ranitidine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00031	0.00256	CcSEcCtD
Ranitidine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00031	0.00256	CcSEcCtD
Ranitidine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000309	0.00255	CcSEcCtD
Ranitidine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000309	0.00255	CcSEcCtD
Ranitidine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000308	0.00254	CcSEcCtD
Ranitidine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000307	0.00253	CcSEcCtD
Ranitidine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000305	0.00251	CcSEcCtD
Ranitidine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000303	0.0025	CcSEcCtD
Ranitidine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000302	0.00249	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000299	0.00247	CcSEcCtD
Ranitidine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000298	0.00245	CcSEcCtD
Ranitidine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000298	0.00245	CcSEcCtD
Ranitidine—Pain—Formoterol—chronic obstructive pulmonary disease	0.000298	0.00245	CcSEcCtD
Ranitidine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000298	0.00245	CcSEcCtD
Ranitidine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000297	0.00245	CcSEcCtD
Ranitidine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000293	0.00241	CcSEcCtD
Ranitidine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000292	0.00241	CcSEcCtD
Ranitidine—Pain—Montelukast—chronic obstructive pulmonary disease	0.000292	0.0024	CcSEcCtD
Ranitidine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000291	0.00239	CcSEcCtD
Ranitidine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000288	0.00237	CcSEcCtD
Ranitidine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000288	0.00237	CcSEcCtD
Ranitidine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000287	0.00236	CcSEcCtD
Ranitidine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000287	0.00236	CcSEcCtD
Ranitidine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000286	0.00236	CcSEcCtD
Ranitidine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000285	0.00235	CcSEcCtD
Ranitidine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000281	0.00231	CcSEcCtD
Ranitidine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000281	0.00231	CcSEcCtD
Ranitidine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000276	0.00228	CcSEcCtD
Ranitidine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000276	0.00228	CcSEcCtD
Ranitidine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000275	0.00227	CcSEcCtD
Ranitidine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000275	0.00227	CcSEcCtD
Ranitidine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000275	0.00227	CcSEcCtD
Ranitidine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000275	0.00227	CcSEcCtD
Ranitidine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000274	0.00226	CcSEcCtD
Ranitidine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000272	0.00224	CcSEcCtD
Ranitidine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000272	0.00224	CcSEcCtD
Ranitidine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000272	0.00224	CcSEcCtD
Ranitidine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000271	0.00223	CcSEcCtD
Ranitidine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000271	0.00223	CcSEcCtD
Ranitidine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00027	0.00222	CcSEcCtD
Ranitidine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.00027	0.00222	CcSEcCtD
Ranitidine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000269	0.00222	CcSEcCtD
Ranitidine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000269	0.00222	CcSEcCtD
Ranitidine—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000265	0.00218	CcSEcCtD
Ranitidine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000261	0.00215	CcSEcCtD
Ranitidine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00026	0.00214	CcSEcCtD
Ranitidine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00026	0.00214	CcSEcCtD
Ranitidine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000256	0.00211	CcSEcCtD
Ranitidine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000256	0.00211	CcSEcCtD
Ranitidine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000256	0.00211	CcSEcCtD
Ranitidine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000251	0.00207	CcSEcCtD
Ranitidine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000246	0.00203	CcSEcCtD
Ranitidine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000246	0.00203	CcSEcCtD
Ranitidine—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000246	0.00202	CcSEcCtD
Ranitidine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000242	0.00199	CcSEcCtD
Ranitidine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000241	0.00199	CcSEcCtD
Ranitidine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000238	0.00196	CcSEcCtD
Ranitidine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000238	0.00196	CcSEcCtD
Ranitidine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000237	0.00195	CcSEcCtD
Ranitidine—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000236	0.00194	CcSEcCtD
Ranitidine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000233	0.00192	CcSEcCtD
Ranitidine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000232	0.00191	CcSEcCtD
Ranitidine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000231	0.0019	CcSEcCtD
Ranitidine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00023	0.0019	CcSEcCtD
Ranitidine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00023	0.0019	CcSEcCtD
Ranitidine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000225	0.00186	CcSEcCtD
Ranitidine—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000225	0.00185	CcSEcCtD
Ranitidine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000225	0.00185	CcSEcCtD
Ranitidine—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000222	0.00183	CcSEcCtD
Ranitidine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000221	0.00182	CcSEcCtD
Ranitidine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000221	0.00182	CcSEcCtD
Ranitidine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000219	0.00181	CcSEcCtD
Ranitidine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000219	0.00181	CcSEcCtD
Ranitidine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000219	0.00181	CcSEcCtD
Ranitidine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000219	0.00181	CcSEcCtD
Ranitidine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000218	0.0018	CcSEcCtD
Ranitidine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000218	0.0018	CcSEcCtD
Ranitidine—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000218	0.00179	CcSEcCtD
Ranitidine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000218	0.00179	CcSEcCtD
Ranitidine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000217	0.00179	CcSEcCtD
Ranitidine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000217	0.00178	CcSEcCtD
Ranitidine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000215	0.00177	CcSEcCtD
Ranitidine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000215	0.00177	CcSEcCtD
Ranitidine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000214	0.00176	CcSEcCtD
Ranitidine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000214	0.00176	CcSEcCtD
Ranitidine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000211	0.00174	CcSEcCtD
Ranitidine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000209	0.00172	CcSEcCtD
Ranitidine—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000208	0.00171	CcSEcCtD
Ranitidine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000207	0.00171	CcSEcCtD
Ranitidine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000207	0.00171	CcSEcCtD
Ranitidine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000207	0.0017	CcSEcCtD
Ranitidine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000207	0.0017	CcSEcCtD
Ranitidine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000207	0.0017	CcSEcCtD
Ranitidine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000206	0.0017	CcSEcCtD
Ranitidine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000202	0.00167	CcSEcCtD
Ranitidine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000196	0.00162	CcSEcCtD
Ranitidine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.00161	CcSEcCtD
Ranitidine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000194	0.0016	CcSEcCtD
Ranitidine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000192	0.00158	CcSEcCtD
Ranitidine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000188	0.00155	CcSEcCtD
Ranitidine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000184	0.00151	CcSEcCtD
Ranitidine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000182	0.0015	CcSEcCtD
Ranitidine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000172	0.00142	CcSEcCtD
Ranitidine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.00017	0.0014	CcSEcCtD
Ranitidine—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.00017	0.0014	CcSEcCtD
Ranitidine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000168	0.00138	CcSEcCtD
Ranitidine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000161	0.00133	CcSEcCtD
Ranitidine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000158	0.0013	CcSEcCtD
Ranitidine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000156	0.00128	CcSEcCtD
Ranitidine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000155	0.00128	CcSEcCtD
Ranitidine—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000155	0.00128	CcSEcCtD
Ranitidine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000154	0.00127	CcSEcCtD
Ranitidine—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000153	0.00126	CcSEcCtD
Ranitidine—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000151	0.00125	CcSEcCtD
Ranitidine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000151	0.00124	CcSEcCtD
Ranitidine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00015	0.00123	CcSEcCtD
Ranitidine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000143	0.00118	CcSEcCtD
Ranitidine—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000143	0.00118	CcSEcCtD
Ranitidine—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000141	0.00116	CcSEcCtD
Ranitidine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000139	0.00114	CcSEcCtD
Ranitidine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000137	0.00113	CcSEcCtD
Ranitidine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000134	0.0011	CcSEcCtD
Ranitidine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000132	0.00109	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000125	0.00103	CcSEcCtD
Ranitidine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000125	0.00103	CcSEcCtD
Ranitidine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000124	0.00102	CcSEcCtD
Ranitidine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.000979	CcSEcCtD
Ranitidine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.000978	CcSEcCtD
Ranitidine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.000972	CcSEcCtD
Ranitidine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000964	CcSEcCtD
Ranitidine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000929	CcSEcCtD
Ranitidine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.000922	CcSEcCtD
Ranitidine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000896	CcSEcCtD
Ranitidine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000892	CcSEcCtD
Ranitidine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000892	CcSEcCtD
Ranitidine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000831	CcSEcCtD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	9.75e-05	0.00271	CbGpPWpGaD
Ranitidine—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	9.75e-05	0.00271	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	9.75e-05	0.00271	CbGpPWpGaD
Ranitidine—Pruritus—Prednisone—chronic obstructive pulmonary disease	9.69e-05	0.000798	CcSEcCtD
Ranitidine—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	9.61e-05	0.00267	CbGpPWpGaD
Ranitidine—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	9.49e-05	0.00264	CbGpPWpGaD
Ranitidine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	9.37e-05	0.000772	CcSEcCtD
Ranitidine—CYP3A5—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.33e-05	0.00259	CbGpPWpGaD
Ranitidine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9.3e-05	0.00259	CbGpPWpGaD
Ranitidine—HRH2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	9.3e-05	0.00258	CbGpPWpGaD
Ranitidine—CYP3A5—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.22e-05	0.00256	CbGpPWpGaD
Ranitidine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	9.18e-05	0.00255	CbGpPWpGaD
Ranitidine—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	9.12e-05	0.00253	CbGpPWpGaD
Ranitidine—HRH2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	9.11e-05	0.00253	CbGpPWpGaD
Ranitidine—Dizziness—Prednisone—chronic obstructive pulmonary disease	9.06e-05	0.000746	CcSEcCtD
Ranitidine—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	8.96e-05	0.00249	CbGpPWpGaD
Ranitidine—Vomiting—Prednisone—chronic obstructive pulmonary disease	8.71e-05	0.000717	CcSEcCtD
Ranitidine—HRH2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	8.67e-05	0.00241	CbGpPWpGaD
Ranitidine—Rash—Prednisone—chronic obstructive pulmonary disease	8.64e-05	0.000711	CcSEcCtD
Ranitidine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	8.63e-05	0.00071	CcSEcCtD
Ranitidine—Headache—Prednisone—chronic obstructive pulmonary disease	8.58e-05	0.000707	CcSEcCtD
Ranitidine—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	8.56e-05	0.00238	CbGpPWpGaD
Ranitidine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	8.37e-05	0.00233	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	8.35e-05	0.00232	CbGpPWpGaD
Ranitidine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	8.26e-05	0.0023	CbGpPWpGaD
Ranitidine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.2e-05	0.00228	CbGpPWpGaD
Ranitidine—Nausea—Prednisone—chronic obstructive pulmonary disease	8.14e-05	0.00067	CcSEcCtD
Ranitidine—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	7.98e-05	0.00222	CbGpPWpGaD
Ranitidine—HRH2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	7.97e-05	0.00221	CbGpPWpGaD
Ranitidine—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	7.94e-05	0.00221	CbGpPWpGaD
Ranitidine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.88e-05	0.00219	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	7.87e-05	0.00219	CbGpPWpGaD
Ranitidine—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	7.78e-05	0.00216	CbGpPWpGaD
Ranitidine—HRH2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	7.76e-05	0.00216	CbGpPWpGaD
Ranitidine—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.75e-05	0.00216	CbGpPWpGaD
Ranitidine—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.65e-05	0.00213	CbGpPWpGaD
Ranitidine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.54e-05	0.0021	CbGpPWpGaD
Ranitidine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	7.52e-05	0.00209	CbGpPWpGaD
Ranitidine—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	7.4e-05	0.00206	CbGpPWpGaD
Ranitidine—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.21e-05	0.002	CbGpPWpGaD
Ranitidine—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.13e-05	0.00198	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	6.99e-05	0.00194	CbGpPWpGaD
Ranitidine—HRH2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	6.93e-05	0.00193	CbGpPWpGaD
Ranitidine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	6.78e-05	0.00189	CbGpPWpGaD
Ranitidine—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	6.66e-05	0.00185	CbGpPWpGaD
Ranitidine—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.63e-05	0.00184	CbGpPWpGaD
Ranitidine—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.56e-05	0.00182	CbGpPWpGaD
Ranitidine—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.47e-05	0.0018	CbGpPWpGaD
Ranitidine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.39e-05	0.00178	CbGpPWpGaD
Ranitidine—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.38e-05	0.00177	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	6.35e-05	0.00176	CbGpPWpGaD
Ranitidine—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	6.23e-05	0.00173	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	6.14e-05	0.00171	CbGpPWpGaD
Ranitidine—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	6.12e-05	0.0017	CbGpPWpGaD
Ranitidine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	6.08e-05	0.00169	CbGpPWpGaD
Ranitidine—HRH2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	6.07e-05	0.00169	CbGpPWpGaD
Ranitidine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	6e-05	0.00167	CbGpPWpGaD
Ranitidine—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.99e-05	0.00167	CbGpPWpGaD
Ranitidine—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.94e-05	0.00165	CbGpPWpGaD
Ranitidine—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.91e-05	0.00164	CbGpPWpGaD
Ranitidine—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.86e-05	0.00163	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—APIP—chronic obstructive pulmonary disease	5.83e-05	0.00162	CbGpPWpGaD
Ranitidine—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.63e-05	0.00157	CbGpPWpGaD
Ranitidine—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.62e-05	0.00156	CbGpPWpGaD
Ranitidine—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.56e-05	0.00154	CbGpPWpGaD
Ranitidine—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.55e-05	0.00154	CbGpPWpGaD
Ranitidine—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.51e-05	0.00153	CbGpPWpGaD
Ranitidine—SLC22A8—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	5.46e-05	0.00152	CbGpPWpGaD
Ranitidine—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.44e-05	0.00151	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	5.39e-05	0.0015	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.07e-05	0.00141	CbGpPWpGaD
Ranitidine—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5e-05	0.00139	CbGpPWpGaD
Ranitidine—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.93e-05	0.00137	CbGpPWpGaD
Ranitidine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.93e-05	0.00137	CbGpPWpGaD
Ranitidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	4.92e-05	0.00137	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	4.65e-05	0.00129	CbGpPWpGaD
Ranitidine—SLC22A8—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.62e-05	0.00128	CbGpPWpGaD
Ranitidine—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.6e-05	0.00128	CbGpPWpGaD
Ranitidine—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.59e-05	0.00128	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	4.57e-05	0.00127	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	4.57e-05	0.00127	CbGpPWpGaD
Ranitidine—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.53e-05	0.00126	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	4.53e-05	0.00126	CbGpPWpGaD
Ranitidine—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.53e-05	0.00126	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.38e-05	0.00122	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	4.38e-05	0.00122	CbGpPWpGaD
Ranitidine—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.35e-05	0.00121	CbGpPWpGaD
Ranitidine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.34e-05	0.00121	CbGpPWpGaD
Ranitidine—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.29e-05	0.00119	CbGpPWpGaD
Ranitidine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.29e-05	0.00119	CbGpPWpGaD
Ranitidine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	4.28e-05	0.00119	CbGpPWpGaD
Ranitidine—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.22e-05	0.00117	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	4.19e-05	0.00116	CbGpPWpGaD
Ranitidine—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.17e-05	0.00116	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	4.11e-05	0.00114	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	4.11e-05	0.00114	CbGpPWpGaD
Ranitidine—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.01e-05	0.00111	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.98e-05	0.00111	CbGpPWpGaD
Ranitidine—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.95e-05	0.0011	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.95e-05	0.0011	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.92e-05	0.00109	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	3.91e-05	0.00109	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	3.91e-05	0.00109	CbGpPWpGaD
Ranitidine—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.89e-05	0.00108	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.86e-05	0.00107	CbGpPWpGaD
Ranitidine—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.84e-05	0.00107	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—GC—chronic obstructive pulmonary disease	3.76e-05	0.00105	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.75e-05	0.00104	CbGpPWpGaD
Ranitidine—HRH2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.75e-05	0.00104	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	3.71e-05	0.00103	CbGpPWpGaD
Ranitidine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.6e-05	0.001	CbGpPWpGaD
Ranitidine—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.58e-05	0.000995	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.56e-05	0.000989	CbGpPWpGaD
Ranitidine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.55e-05	0.000988	CbGpPWpGaD
Ranitidine—SLC22A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	3.54e-05	0.000985	CbGpPWpGaD
Ranitidine—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.53e-05	0.000981	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	3.5e-05	0.000974	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.49e-05	0.000972	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.43e-05	0.000953	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	3.42e-05	0.000951	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	3.41e-05	0.000947	CbGpPWpGaD
Ranitidine—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.39e-05	0.000943	CbGpPWpGaD
Ranitidine—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.35e-05	0.00093	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	3.22e-05	0.000896	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	3.18e-05	0.000884	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.11e-05	0.000865	CbGpPWpGaD
Ranitidine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.01e-05	0.000836	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3e-05	0.000834	CbGpPWpGaD
Ranitidine—SLC22A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3e-05	0.000833	CbGpPWpGaD
Ranitidine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.96e-05	0.000824	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	2.92e-05	0.000812	CbGpPWpGaD
Ranitidine—SLC22A8—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.78e-05	0.000771	CbGpPWpGaD
Ranitidine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.76e-05	0.000768	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.74e-05	0.000762	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.73e-05	0.000759	CbGpPWpGaD
Ranitidine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.72e-05	0.000757	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.71e-05	0.000755	CbGpPWpGaD
Ranitidine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.62e-05	0.000728	CbGpPWpGaD
Ranitidine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.58e-05	0.000718	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.55e-05	0.000709	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.5e-05	0.000694	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.35e-05	0.000654	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.32e-05	0.000645	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.3e-05	0.00064	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.27e-05	0.00063	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	2.26e-05	0.000628	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	2.2e-05	0.000613	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.13e-05	0.000593	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.12e-05	0.000589	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.11e-05	0.000586	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.1e-05	0.000584	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.1e-05	0.000583	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	2.08e-05	0.000577	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.05e-05	0.000571	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.05e-05	0.000569	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.03e-05	0.000564	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.95e-05	0.000541	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.93e-05	0.000537	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.92e-05	0.000535	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.91e-05	0.000531	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.85e-05	0.000515	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.84e-05	0.000511	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.83e-05	0.000509	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.81e-05	0.000503	CbGpPWpGaD
Ranitidine—SLC22A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.8e-05	0.0005	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.76e-05	0.000489	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.76e-05	0.000488	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.71e-05	0.000475	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.71e-05	0.000474	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.68e-05	0.000467	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.67e-05	0.000465	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.65e-05	0.000458	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.64e-05	0.000455	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.6e-05	0.000443	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	1.58e-05	0.000438	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.57e-05	0.000436	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	1.44e-05	0.0004	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.42e-05	0.000396	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.41e-05	0.000391	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.4e-05	0.00039	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.4e-05	0.000388	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.38e-05	0.000385	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.36e-05	0.000377	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.34e-05	0.000373	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.33e-05	0.000369	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.31e-05	0.000364	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.3e-05	0.000362	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.28e-05	0.000356	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.26e-05	0.000351	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.24e-05	0.000345	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.23e-05	0.000343	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.22e-05	0.000339	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.2e-05	0.000335	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.19e-05	0.000331	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.14e-05	0.000316	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.14e-05	0.000316	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.13e-05	0.000315	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.12e-05	0.000312	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.11e-05	0.000309	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.11e-05	0.000307	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.09e-05	0.000303	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.09e-05	0.000302	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.08e-05	0.0003	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.05e-05	0.000293	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.03e-05	0.000286	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.02e-05	0.000285	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.02e-05	0.000284	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.02e-05	0.000282	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1e-05	0.000278	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.63e-06	0.000268	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.61e-06	0.000267	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	9.5e-06	0.000264	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.43e-06	0.000262	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.23e-06	0.000257	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.86e-06	0.000246	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	8.67e-06	0.000241	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.55e-06	0.000238	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.47e-06	0.000235	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.43e-06	0.000234	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—ALB—chronic obstructive pulmonary disease	8.43e-06	0.000234	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.34e-06	0.000232	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.3e-06	0.000231	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.23e-06	0.000229	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—NOS3—chronic obstructive pulmonary disease	8.06e-06	0.000224	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.86e-06	0.000219	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.86e-06	0.000218	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.75e-06	0.000216	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.67e-06	0.000213	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.45e-06	0.000207	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.42e-06	0.000206	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	7.33e-06	0.000204	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.27e-06	0.000202	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.23e-06	0.000201	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.97e-06	0.000194	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.85e-06	0.00019	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	6.69e-06	0.000186	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.66e-06	0.000185	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.57e-06	0.000183	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	6.55e-06	0.000182	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.38e-06	0.000177	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	6.26e-06	0.000174	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.16e-06	0.000171	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.12e-06	0.00017	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.8e-06	0.000161	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.14e-06	0.000143	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.07e-06	0.000141	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	5.06e-06	0.000141	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	4.94e-06	0.000137	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	4.84e-06	0.000135	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.73e-06	0.000131	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.72e-06	0.000131	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	4.66e-06	0.000129	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.48e-06	0.000124	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	4.45e-06	0.000124	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.94e-06	0.00011	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.77e-06	0.000105	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.04e-06	8.46e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.91e-06	8.09e-05	CbGpPWpGaD
